Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| International Stem Cell CORPISCO.OB · Entity 8432 | VP, Legal Affairs & Operations | June 09, 2021 | June 11, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
International Stem Cell CORP
Report date June 09, 2021 · Filed June 11, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.39 · Expires 2031-06-09 | Direct | 250,000 |
Reported balance
After 2021-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-09 · Grant · Acquired 250,000 · Balance 250,000 F1: 3/36th of the shares underlying such options shall vest on 09/09/2021, and the remaining share in equal monthly installments over a period of 33 months. |
Filing footnotes · ownership attribution and instrument terms
F1: 3/36th of the shares underlying such options shall vest on 09/09/2021, and the remaining share in equal monthly installments over a period of 33 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2021 Filed Jun 11, 2021 18:37 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001683168-21-002478 · ownership.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2031-06-09 F1 · derivative.exercise_date: 3/36th of the shares underlying such options shall vest on 09/09/2021, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 21:38 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001683168-19-000536 · ownership.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2029-02-28 F1 · derivative.exercise_date: 3/36th of the shares underlying such options shall vest on May 28, 2019, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 12:59 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,858 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001683168-18-003617 · ownership.xml · derivative · entry 5 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,273 Underlying: Common Stock · 47,858 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 12:59 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,778 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-003617 · ownership.xml · derivative · entry 4 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 11,111 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 12:59 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 10,636 | $1.54 | $16,379.44 |
DisclosureSEC source: 0001683168-18-003617 · ownership.xml · nonDerivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.54 per share. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 12:59 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 7,858 | $1.10 | $8,643.80 |
DisclosureSEC source: 0001683168-18-003617 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 12:59 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 2,778 | $1.09 | $3,028.02 |
DisclosureSEC source: 0001683168-18-003617 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 20:45 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,494 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001683168-18-002939 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,858 Underlying: Common Stock · 49,352 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 20:45 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 1,494 | $1.58 | $2,360.52 |
DisclosureSEC source: 0001683168-18-002939 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share. Read SEC document |
| October 02, 2018 Filed Oct 3, 2018 20:45 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 1,494 | $1.10 | $1,643.40 |
DisclosureSEC source: 0001683168-18-002939 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 22:14 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001683168-18-002467 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,352 Underlying: Common Stock · 54,252 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 22:14 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 4,900 | $1.58 | $7,742.00 |
DisclosureSEC source: 0001683168-18-002467 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 22:14 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 4,900 | $1.10 | $5,390.00 |
DisclosureSEC source: 0001683168-18-002467 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,167 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:57 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,748 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001683168-18-002459 · ownership.xml · derivative · entry 5 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,252 Underlying: Common Stock · 60,000 shares Expires 2027-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:57 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,556 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-002459 · ownership.xml · derivative · entry 4 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111 Underlying: Common Stock · 14,667 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:57 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 9,304 | $1.58 | $14,700.32 |
DisclosureSEC source: 0001683168-18-002459 · ownership.xml · nonDerivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:57 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 5,748 | $1.10 | $6,322.80 |
DisclosureSEC source: 0001683168-18-002459 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 21, 2018 20:57 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 3,556 | $1.09 | $3,876.04 |
DisclosureSEC source: 0001683168-18-002459 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 17:17 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001683168-18-002400 · ownership.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-06-21 F1 · derivative.exercise_date: Vesting start date - June 21, 2018. 3/36th of the shares underlying such options shall vest on September 21, 2018, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
| August 15, 2018 Filed Sep 27, 2018 19:02 UTC Amendment | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.58 | $0.00 |
DisclosureSEC source: 0001683168-18-002866 · ownership.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-08-15 F1 · derivative.exercise_date: 3/36th of the shares underlying such options shall vest on September 21, 2018, and the remaining share in equal monthly installments over a period of 33 months. This amendment is being filed to correct the previously reported expiration date of the stock option. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 21:46 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,100 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-001975 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,667 Underlying: Common Stock · 15,767 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 21:46 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 1,100 | $1.58 | $1,738.00 |
DisclosureSEC source: 0001683168-18-001975 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share. Read SEC document |
| July 13, 2018 Filed Jul 17, 2018 21:46 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 1,100 | $1.09 | $1,199.00 |
DisclosureSEC source: 0001683168-18-001975 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:20 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,833 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-001945 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,767 Underlying: Common Stock · 18,600 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:20 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 2,833 | $1.58 | $4,476.14 |
DisclosureSEC source: 0001683168-18-001945 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share. Read SEC document |
| July 10, 2018 Filed Jul 12, 2018 21:20 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 2,833 | $1.09 | $3,087.97 |
DisclosureSEC source: 0001683168-18-001945 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:53 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 200 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-001809 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Underlying: Stock Option (Right to Buy) · 18,800 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:53 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 200 | $1.59 | $318.00 |
DisclosureSEC source: 0001683168-18-001809 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.59 per share. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:53 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 200 | $1.09 | $218.00 |
DisclosureSEC source: 0001683168-18-001809 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 22:05 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-18-001801 · ownership.xml · derivative · entry 3 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 Underlying: Common Stock · 20,000 shares Expires 2027-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 22:05 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | SaleCommon Stock | 1,200 | $1.60 | $1,920.00 |
DisclosureSEC source: 0001683168-18-001801 · ownership.xml · nonDerivative · entry 2 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267 F1 · price: The reported shares were sold in open market transactions through a broker-dealer at $1.60 per share. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 22:05 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | Exercise / conversionCommon Stock | 1,200 | $1.09 | $1,308.00 |
DisclosureSEC source: 0001683168-18-001801 · ownership.xml · nonDerivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 20:20 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $1.10 | $0.00 |
DisclosureSEC source: 0001683168-17-001466 · garnette_f4.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2027-05-31 F1 · derivative.exercise_date: 3/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 20:35 UTC | International Stem Cell CORP ISCO.OB · Entity 8432 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.09 | $0.00 |
DisclosureSEC source: 0001683168-17-000346 · garnette_f4.xml · derivative · entry 1 Garnette Sophia · CIK 0001616590 · VP, Legal Affairs & Operation 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-02-10 F1 · derivative.exercise_date: 3/36th of the shares underlying such options shall vest on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.